These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34939346)

  • 1. Serum troponin, D-dimer, and CRP level in severe coronavirus (COVID-19) patients.
    Ali AM; Rostam HM; Fatah MH; Noori CM; Ali KM; Tawfeeq HM
    Immun Inflamm Dis; 2022 Mar; 10(3):e582. PubMed ID: 34939346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].
    Xu Y; Qian Y; Gu Q; Tang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):559-563. PubMed ID: 32576347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation profile and correlation between D-dimer, inflammatory markers, and COVID-19 severity in an Indonesian national referral hospital.
    Sukrisman L; Sinto R
    J Int Med Res; 2021 Nov; 49(11):3000605211059939. PubMed ID: 34796762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Infection-Dependent Modulation in Vital Components of the Serum Profile of Severely SARS-CoV-2 Infected Patients.
    Izhari MA
    Infect Drug Resist; 2024; 17():1653-1667. PubMed ID: 38707987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use and misuse of biomarkers and the role of D-dimer and C-reactive protein in the management of COVID-19: A post-hoc analysis of a prospective cohort study.
    Gonçalves FAR; Besen BAMP; Lima CA; Corá AP; Pereira AJR; Perazzio SF; Gouvea CP; Fonseca LAM; Trindade EM; Sumita NM; Duarte AJDS; Lichtenstein A; ; Bonfa E; Utiyama EM; Segurado AC; Perondi B; Miethke-Morais A; Montal AC; Harima L; Fusco SRG; Silva MF; Rocha MC; Marcilio I; Rios IC; Kawano FYO; Jesus MA; Kallas ÉG; Carmo C; Tanaka C; Souza HP; Marchini JFM; Carvalho C; Ferreira JC; Levin ASS; Oliveira MS; Guimarães T; Lázari CDS; Sabino E; Magri MMC; Barros-Filho TEP; Francisco MCPB; Costa SF
    Clinics (Sao Paulo); 2021; 76():e3547. PubMed ID: 34909913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.
    Li C; Jiang J; Wang F; Zhou N; Veronese G; Moslehi JJ; Ammirati E; Wang DW
    J Mol Cell Cardiol; 2020 Oct; 147():74-87. PubMed ID: 32827510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THE RELATIONSHIP BETWEEN ESR AND C-REACTIVE PROTEIN WITH VARIABLE LEVEL OF D-DIMER IN COVID-19.
    Hasan HA; Almubarak N; Jeber MA
    Wiad Lek; 2021; 74(12):3172-3178. PubMed ID: 35058385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic role of D-dimer in hospitalized COVID-19 patients.
    Korkusuz R; Karandere F; Senoglu S; Kocoglu H; Yasar KK
    Bratisl Lek Listy; 2021; 122(11):811-815. PubMed ID: 34672673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.
    Velavan TP; Kuk S; Linh LTK; Lamsfus Calle C; Lalremruata A; Pallerla SR; Kreidenweiss A; Held J; Esen M; Gabor J; Neurohr EM; Shamsrizi P; Fathi A; Biecker E; Berg CP; Ramharter M; Addo MM; Kreuels B; Kremsner PG
    Sci Rep; 2021 Jul; 11(1):14471. PubMed ID: 34262116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the impact and efficacy of routine immunological, biochemical and hematological biomarkers as predictors of COVID-19 mortality?
    Tahir Huyut M; Huyut Z; İlkbahar F; Mertoğlu C
    Int Immunopharmacol; 2022 Apr; 105():108542. PubMed ID: 35063753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
    Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of daily troponin I and D-dimer serum levels on mortality in COVID-19 pneumonia patients.
    Stavileci B; Ereren E; Özdemir E; Özdemir B; Cengiz M; Enar R
    Cardiovasc J Afr; 2023 Jan-Apr 23; 34(1):16-22. PubMed ID: 35687085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cohort study of 676 patients indicates D-dimer is a critical risk factor for the mortality of COVID-19.
    Huang Y; Lyu X; Li D; Wang L; Wang Y; Zou W; Wei Y; Wu X
    PLoS One; 2020; 15(11):e0242045. PubMed ID: 33166991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Features and Blood Indicators for Severity and Prognosis in COVID-19 Patients.
    Liu J; Gong S; Lv J; Wang G; Guo Y; Gao D; Zhang D; Ma S; Luo H; Yang H; Ma X
    Clin Lab; 2023 Apr; 69(4):. PubMed ID: 37057951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of D-dimer, inflammatory markers, cytokines abnormality, and disease severity in COVID-19 severe/critical patients in Wuhan].
    Zhang J; Gao XL; Li DJ; Jiang Y; Liu Y; Pang L; Xu D; Yang LH
    Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):927-931. PubMed ID: 33333696
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing the Impact of Inflammatory Markers and CT Severity Score on Disease Severity of COVID-19 Patients Admitted to ICU at a Tertiary Hospital.
    Kurri N; Tyagi B; Singhal E; Gupta N; Agarwal AK; Gupta V; Rai G; Bindra MS
    J Assoc Physicians India; 2021 Jun; 69(6):11-12. PubMed ID: 34472783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
    Dujardin RWG; Hilderink BN; Haksteen WE; Middeldorp S; Vlaar APJ; Thachil J; Müller MCA; Juffermans NP
    Thromb Res; 2020 Dec; 196():308-312. PubMed ID: 32977128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Composite Study of Coagulation Milieu in Covid-19: Experience from a Tertiary Care Centre from India.
    Bohra GK; Purohit A; Kumar D; Garg MK; Midha NK; Manglia R; Jain K; Didel S; Nag V; Sharma P; Sharma A; Bhatia P; Misra S
    Cardiovasc Hematol Disord Drug Targets; 2021; 21(3):185-195. PubMed ID: 34852756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of some hematological parameters between male and female patients infected with COVID-19.
    Abed HH; Al-Ziaydi AG; Taher IA; Al Dulaimi AK
    Hum Antibodies; 2022; 30(3):151-155. PubMed ID: 35786649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.